Can changing the terminology for benign aspirates reduce the atypia of undetermined significance/ follicular lesion of undetermined significance rate in thyroid fine-needle aspirates?

Cancer Cytopathology

Volumn 121, Issue 4, 2013, Pages 175-178

  Renshaw, Andrew A ^a   Krane, Jeffrey F ^b  

^a BAPTIST HOSPITAL OF MIAMI   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPIA OF UNDETERMINED SIGNIFICANCE FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE; BENIGN TUMOR; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER RISK; CLINICAL CLASSIFICATION; CYTOPATHOLOGY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FALSE NEGATIVE RESULT; FINE NEEDLE ASPIRATION BIOPSY; GOLD STANDARD; HUMAN; MEDICAL TERMINOLOGY; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; THYROID PAPILLARY CARCINOMA; TUMOR CLASSIFICATION; ADENOCARCINOMA; ARTICLE; CLASSIFICATION; PATHOLOGY; THYROID GLAND; THYROID TUMOR; ATYPIA OF UNDETERMINED SIGNIFICANCE; CANCER DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE; ONCOLOGICAL PARAMETERS;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; HUMANS; THYROID GLAND; THYROID NEOPLASMS;

MLCS; MLOWN;

EID: 84878427884     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.21236     Document Type: Note

References (11)

1. Krane JF, Vanderlaan PA, Faquin WC, Renshaw AA. The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: A proposed performance measure for reporting in the Bethesda System for thyroid cytopathology. Cancer (Cancer Cytopathol). 2012;120:111-116.
2. Henry M. The potential for overuse of atypical thyroid diagnoses. Cancer (Cancer Cytopathol). 2012;120:108-110.
3. Bongiovanni M, Krane JF, Cibas ES, Faquin WC. The atypical thyroid fine-needle aspiration: Past, present, and future. Cancer (Cancer Cytopathol). 2012;120:73-86.
4. VanderLaan PA, Renshaw AA, Krane JF. Atypia of undetermined significance and nondiagnostic rates in The Bethesda System for Reporting Thyroid Cytopathology are inversely related. Am J Clin Pathol. 2012;137:462-465.
5. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology. New York: Springer; 2010.
6. Renshaw AA. Focal features of papillary carcinoma of the thyroid in fine needle aspiration material are strongly associated with papillary carcinoma at resection. Am J Clin Pathol. 2002;118:208-210.
7. Wu HH, Jones JN, Grzybicki DM, Elsheikh TM. Sensitive cytologic criteria for the identification of follicular variant of papillary thyroid carcinoma in fine-needle aspiration biopsy. Diagn Cytopathol. 2003;29:262-266.
8. Renshaw AA. Does a repeated benign aspirate change the risk of malignancy after an initial atypical thyroid fine-needle aspiration? Am J Clin Pathol. 2010;134:788-792.
9. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: Should repeated FNA be the preferred initial approach? Am J Clin Pathol. 2011;135:770-775.
10. Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer (Cancer Cytopathol). 2010;118:415-422.
11. Renshaw AA. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer (Cancer Cytopathol). 2010;118:186-189.